Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Vuong Trieu currently holds 8,491 shares of Oncotelic Therapeutics, Inc. (OTLC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vuong Trieu has been a net buyer of OTLC stock. They have purchased $88.5K and sold $0 worth of shares.
Vuong Trieu's most recent insider trade was on Jan 22, 2026, when they sold 4,426 shares at $0.00 per share.
Vuong Trieu serves as Executive at Oncotelic Therapeutics, Inc. (OTLC). They have executed 28 insider transactions totaling $88.5K over their tenure at the company.
Vuong Trieu holds the position of Executive at Oncotelic Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Vuong Trieu has shown a buying trading pattern, with $88.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Vuong Trieu was on Oct 1, 2018, when they sold $250.0K worth of MRNA shares. This transaction involved 500,000 shares at $0.50 per share.
Vuong Trieu currently owns 8,491 shares of Oncotelic Therapeutics, Inc. (OTLC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Vuong Trieu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Vuong Trieu has 28 Form 4 filings on record as an insider at Oncotelic Therapeutics, Inc..
Set alerts for Vuong Trieu and 40,000+ other insiders.